Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Human Genetics

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004872-199715120-00025PMID 9683587PMCID PMC1377297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The syndrome

  2019cited by this paper
• 11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess

  1997influential reference
• 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.

  1997cited by this paper
• Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: evidence for nuclear localization.

  1997cited by this paper
• Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state

  1997cited by this paper
• Immunodetection of 11β-Hydroxysteroid Dehydrogenase Type 2 in Human Mineralocorticoid Target Tissues: Evidence for Nuclear Localization.

  1997cited by this paper
• Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene

  1996cited by this paper
• Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene.

  1996cited by this paper
• Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man

  1996cited by this paper
• Point mutations abolish 11 beta-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess.

  1996cited by this paper
• Apparent mineralocorticoid excess: type I and type II.

  1996cited by this paper
• Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype.

  1996cited by this paper
• Molecular basis of human 3 beta-hydroxysteroid dehydrogenase deficiency.

  1995cited by this paper
• Apparent mineralocorticoid excess syndromes

  1995cited by this paper
• Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase

  1995influential reference
• The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess.

  1995cited by this paper
• A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess.

  1995cited by this paper
• Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

  1995cited by this paper
• Heterogeneous hypertension

  1995cited by this paper
• Evidence of Coexisting Changes in 11β-Hydroxysteroid Dehydrogenase and 5β-Reductase Activity in Subjects With Untreated Essential Hypertension

  1995cited by this paper
• Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess.

  1995cited by this paper
• Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension.

  1995cited by this paper
• Detection of human 11 beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts.

  1995cited by this paper
• Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme.

  1994cited by this paper
• Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme.

  1994cited by this paper
• Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.

  1994cited by this paper
• Apparent mineralocorticoid excess type II.

  1994cited by this paper
• Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency

  1994cited by this paper
• Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues.

  1994cited by this paper
• Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research.

  1993cited by this paper
• Evidence for Cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess

  1992cited by this paper
• Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess.

  1992cited by this paper
• The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.

  1991cited by this paper
• Licorice-induced hypermineralocorticoidism.

  1991influential reference
• Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.

  1990cited by this paper
• Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

  1988cited by this paper
• Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.

  1988cited by this paper
• Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor.

  1988cited by this paper
• Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

  1987cited by this paper
• NEW FINDINGS IN APPARENT MINERALOCORTICOID EXCESS

  1987cited by this paper
• Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.

  1987cited by this paper
• The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.

  1986influential reference
• Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families.

  1985cited by this paper
• Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.

  1983cited by this paper
• Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.

  1983cited by this paper
• INVESTIGATION OF URINARY STEROID PROFILES AS A DIAGNOSTIC METHOD IN CUSHING'S SYNDROME

  1982cited by this paper
• A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol.

  1979cited by this paper

• Case report: Clinical characteristics and Genetical analysis of HSD11B2 in three Chinese children with apparent mineralocorticoid excess: a case series

  2025cites this paper
• Apparent Mineralocorticoid Excess in Israel: A Case Series and Literature Review.

  2024cites this paper
• A case report of apparent mineralocorticoid excess, with nephrological and neurological symptoms since birth, and with a new probably pathogenic variant in HSD11B2 gene.

  2024cites this paper
• Mechanistic insights into the primary and secondary alterations of renal ion and water transport in the distal nephron

  2022cites this paper
• Apparent mineralocorticoid excess: comprehensive overview of molecular genetics

  2022cites this paper
• Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension

  2021cites this paper
• A narrative review of Hyporeninemic hypertension—an indicator for monogenic forms of hypertension

  2021cites this paper
• A variant in the NEDD4L gene associates with hypertension in chronic kidney disease in the southeastern Han Chinese population.

  2020cites this paper
• Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.

  2019cites this paper
• Alterations of Cortisol Metabolism in Human Disorders

  2018cites this paper
• Guidelines of the Pediatric Section of the Polish Society of Hypertension on diagnosis and treatment of arterial hypertension in children and adolescents

  2018cites this paper
• 11-HSD2 SUMOylation Modulates Cortisol-induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation

  2017cites this paper
• Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency

  2017cites this paper
• Apparent mineralocorticoid excess and the long term treatment of genetic hypertension.

  2017cites this paper
• Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond

  2017cites this paper
• 11&bgr;-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation

  2017cites this paper
• Screening for genetic variants implicated in monogenic forms of hypertension in a hypertensive urban black Free State cohort

  2016influential citation
• Renal tubular disorders of electrolyte regulation in children

  2015cites this paper
• Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders.

  2014cites this paper
• Variants of 11β-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 in Chinese obese adolescents

  2014cites this paper
• 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

  2013cites this paper
• Glucocorticoid synthesis-related genes: HSD11B1 and HSD11B2 in hypertensive disorders in pregnancy

  2013cites this paper
• HSD11B2 CA-repeat and sodium balance

  2013cites this paper
• Role of 11βHSD2 in salt and water homeostasis

  2012cites this paper
• Investigating mechanisms of salt-sensitive hypertension in 11β-HSD2 heterozygote mice

  2011cites this paper
• Hsd11b2 Haploinsufficiency in Mice Causes Salt Sensitivity of Blood Pressure

  2011cites this paper
• A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients

  2011cites this paper
• Functional Analysis of Sequence Variation In silico structure-function analysis of pathological variation in the HSD 11 B 2 gene sequence

  2010influential citation
• Reductive 17beta-hydroxysteroid dehydrogenase types 1, 5 and 7 involved in hormone-dependent cancers : 3D-structure, function and inhibition

  2010cites this paper
• The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.

  2010cites this paper
• In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence.

  2010influential citation
• Heritable forms of hypertension

  2009cites this paper
• The genetics of essential hypertension.

  2008cites this paper
• Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients

  2008cites this paper
• Apparent mineralocorticoid excess syndrome in a Brazilian boy caused by the homozygous missense mutation p.R186C in the HSD11B2 gene.

  2008cites this paper
• Advances in genetic hypertension

  2007cites this paper
• Apparent mineralocorticoid excess: report of six new cases and extensive personal experience.

  2006cites this paper
• Conformational stability of 17β‐hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus

  2006cites this paper
• Genetic Variations of HSD11B2 in Hypertensive Patients and in the General Population, Six Rare Missense/Frameshift Mutations

  2006cites this paper
• Monogenic mineralocorticoid hypertension.

  2006cites this paper
• Phytoestrogens as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase.

  2005cites this paper
• . 11 (cid:1) -Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action

  2005cites this paper
• 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.

  2005cites this paper
• 11 -Hydroxysteroid deshydrogenase: a multi-faceted enzyme

  2005cites this paper
• 11beta-Hydroxysteroid deshydrogenase: a multi-faceted enzyme.

  2005cites this paper
• 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action

  2005cites this paper
• Dimerization and enzymatic activity of fungal 17β-hydroxysteroid dehydrogenase from the short-chain dehydrogenase/reductase superfamily

  2005cites this paper
• Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.

  2005cites this paper
• 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.

  2005cites this paper
• Phytoestrogens as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase.

  2005cites this paper
• Apparent Mineralocorticoid Excess Syndrome : An Overview Mario Palermo

  2005cites this paper
• Genetic manipulation of 11beta-hydroxysteroid dehydrogenases in mice.

  2005cites this paper
• Apparent mineralocorticoid excess syndrome: an overview.

  2004cites this paper
• Characterisation of 11h-hydroxysteroid dehydrogenases in feline kidney and liver

  2004cites this paper
• Characterisation of 11 beta-hydroxysteroid dehydrogenases in feline kidney and liver.

  2004cites this paper
• The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement

  2003cites this paper
• Late-Onset Apparent Mineralocorticoid Excess Caused by Novel Compound Heterozygous Mutations in the HSD11B2 Gene

  2003cites this paper
• Significance of individual amino acid residues for coenzyme and substrate specificity of 17beta-hydroxysteroid dehydrogenase from the fungus Cochliobolus lunatus.

  2003cites this paper
• Grapefruit juice inhibits 11β‐hydroxysteroid dehydrogenase in vivo, in man

  2003cites this paper
• Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research.

  2003cites this paper
• Pathophysiology of adrenal hypertension.

  2002cites this paper
• Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors.

  2002cites this paper
• Impact of the GH-cortisol ratio on the age-dependent changes in body composition.

  2002cites this paper
• Congenital deficiency of 11β-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): Diagnostic value of urinary free cortisol and cortisone

  2001cites this paper
• Evaluation of selected polymorphisms of the Mendelian hypertensive disease genes in the Japanese population.

  2001cites this paper
• 18 Cortisol Metabolism

  2001cites this paper
• Steroid metabolism in metabolic syndrome X.

  2001cites this paper
• Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.

  2001cites this paper
• Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly.

  2001cites this paper
• 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.

  2001cites this paper
• Apparent mineralocorticoid excess.

  2001cites this paper
• Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease.

  2000cites this paper
• Low renin hypertension in the next millennium.

  2000cites this paper
• Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation.

  2000cites this paper
• Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase.

  2000cites this paper
• Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?

  2000cites this paper
• Dexamethasone-suppressible hypertension.

  2000cites this paper
• CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity.

  2000cites this paper
• The role of the 11β‐hydroxysteroid dehydrogenase type 2 in human hypertension

  2000cites this paper
• Hormonal Hypertension in Children: 11β-Hydroxylase Deficiency and Apparent Mineralocorticoid Excess

  2000cites this paper
• 11 beta-Hydroxysteroid dehydrogenase.

  1999cites this paper
• Linkage mapping for hypertension susceptibility genes

  1999cites this paper
• Genetic, biochemical, and clinical studies of patients with A328V or R213C mutations in 11betaHSD2 causing apparent mineralocorticoid excess.

  1999cites this paper
• Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.

  1999cites this paper
• Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.

  1999cites this paper
• The 11beta-hydroxysteroid dehydrogenases: functions and physiological effects.

  1999cites this paper
• Mineralocorticoid hypertension.

  1999cites this paper
• Cortisol as a mineralocorticoid in human disease.

  1999cites this paper
• Cure of apparent mineralocorticoid excess by kidney transplantation.

  1998cites this paper